• Contact
  • EPAD Academy
Top Bar Menu
TwitterFacebookYouTube
Search...
EPADEPAD
EPAD
European Prevention of Alzheimer's Dementia Consortium
  • Home
  • About
    • Welcome to EPAD
    • Project Objectives
    • Project Structure
    • EPAD Partners
    • Coordination & Management
    • EPAD Q&A
  • Our research
    • Participation in EPAD
      • Participation in EPAD Cohort
      • EPAD Study Visits
      • Trial Locations
      • Participation FAQs
    • The Participant’s Experience
      • The Research Participant Panel
      • EPAD Stories
    • The EPAD platform
      • The EPAD Platform
      • EPAD Benefits
      • Clinical Candidate Selection
      • EPAD FAQs
      • Research Resources
  • Open Access Data
    • Overview
    • Access
    • Data
    • MRI Images
  • Sample Access
  • News & Publications
    • Latest News
    • Newsletters
    • Publications
    • Videos
Menu back  

Loading Events

« All Events

  • This event has passed.

14th Human Amyloid Imaging

January 15, 2020 @ 8:00 am - January 17, 2020 @ 5:00 pm

  • « 12th Clinical Trials on Alzheimer’s Disease (CTAD)
  • AAIC 2020 »

The 14th Human Amyloid Imaging will take place in Miami, Florida on January 15-17, 2020.

  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live

Details

Start:
January 15, 2020 @ 8:00 am
End:
January 17, 2020 @ 5:00 pm
Website:
https://hai.worldeventsforum.com/
  • « 12th Clinical Trials on Alzheimer’s Disease (CTAD)
  • AAIC 2020 »
Share this page
FacebookTwitterLinkedInGoogle+
Latest News
  • New paper showing Eigenvector centrality (EC) alterations in the pre-dementia stages of Alzheimer’s disease
    2023-03-28
  • Analysis of multiple steroids in saliva in the EPAD study
    2023-03-02
  • Hormone Replacement Therapy could ward off Alzheimer’s among at-risk women
    2023-01-16
  • Associations between Mediterranean diet and cognition in the pan-European EPAD LCS
    2022-12-09
  • Bruno Steinkraus
    Interview with Dr. Bruno Steinkraus, Chief Scientific Officer at Hummingbird Diagnostics GmbH
    2022-11-25
View the EPAD Brochure
thumbnail of EPAD brochure
Speak to the EPAD team
thumbnail of speech bubbles
Twitter
Twitter
EPAD
EPAD
@IMI_EPAD

We are glad to see some @IMI_EPAD @IMI_AMYPAD members in London for the #EuroPADneuroimaging symposium aiming to present results and estasblish additional collaborations between imaging researchers across cohorts. pic.twitter.com/m30x4PIHMe

reply retweet favorite
12:14 pm · 2023-05-24
Twitter
EPAD
EPAD
@IMI_EPAD

.@silvia_ingala's PhD defense takes place today at 9h45 CEST at the Aula of the @VUamsterdam. You can follow the event online via the VU Beadle's Office channel: youtube.com/@VUBeadlesOffi… @IMI_EPAD @IMI_AMYPAD @IHIEurope @AlzheimerAms

reply retweet favorite
6:15 am · 2023-05-17
Twitter
EPAD
EPAD
@IMI_EPAD

Today, @silvia_ingala will defend her PhD thesis “Before sunset: imaging Alzheimer’s disease in its earliest stages” developed in the context of @IMI_EPAD & @IMI_AMYPAD. Many congratulations on your excellent work. Best of luck and we’re all sending good vibes! @IHIEurope pic.twitter.com/N7Dlewymow

reply retweet favorite
6:11 am · 2023-05-17
Twitter
EPAD
EPAD
@IMI_EPAD

NEW paper analysing biological brain age prediction using machine learning on structural neuroimaging data from ALFA+ ADNI @IMI_EPAD & OASIS cohorts! @cumplido_irene @MahnazShekari @Marta_Mila_ @FBarkhof @M_SuarezCalvet @JuandoGispert @BarcelonaBeta doi.org/10.7554/eLife.…

reply retweet favorite
6:59 am · 2023-05-15
Twitter
EPAD
EPAD
@IMI_EPAD

Apply today to the William H. Gates Sr. Fellowship, a 2-year program aimed at accelerating progress towards new #Alzheimer's disease diagnostics, treatments & cures through data sharing and global collaboration from @AlzData. Applications close June 11th ➡️addi.pub/Fellowship23 twitter.com/AlzData/status…

reply retweet favorite
6:49 am · 2023-05-12
Workstream Progress
Workstream 120%
Workstream 232%
Workstream 310%
Workstream 446%
Contact us

Submitclear

Recent Posts
  • New paper showing Eigenvector centrality (EC) alterations in the pre-dementia stages of Alzheimer’s disease
  • Analysis of multiple steroids in saliva in the EPAD study
  • Hormone Replacement Therapy could ward off Alzheimer’s among at-risk women
  • Associations between Mediterranean diet and cognition in the pan-European EPAD LCS
  • Interview with Dr. Bruno Steinkraus, Chief Scientific Officer at Hummingbird Diagnostics GmbH
Recent Comments
  • The EPAD genomic data is now available on the Alzheimer’s Disease Workbench on The EPAD genomic data is now available on the Alzheimer’s Disease Workbench
  • ADDI celebrates one year of achievements – Neuronet on ADDI celebrates one year of achievements
  • EPAD dataset is now available on the Alzheimer’s Disease Workbench on The final EPAD dataset is now available on the Alzheimer’s Disease Workbench
  • The final EPAD dataset is now available to the entire research community on The final EPAD dataset is now available to the entire research community
  • The ERC has awarded an ERC grant to identify age-related human blood factors as a therapeutic target for Alzheimer’s disease – Neuronet on New ERC starting grant to identify age-related human blood factors as a therapeutic target for Alzheimer’s disease
Archives
  • March 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • January 2022
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • June 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • June 2015
  • May 2015
  • April 2015
Categories
  • EPAD Academy
  • News
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Copyright © 2015-2021 EPAD | Created by CMAST and Aridhia
  • Acronyms
  • Legal Notice
  • Privacy Policy
Bottom Menu

efpia-logo EU imi logo

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD grant agreement nº 115736

This website uses cookies to improve your experience. Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT